- 2022 - 2025 消化器癌の革新的治療法開発を目指したハダカデバネズミ腸内細菌のマルチオミクス解析
- 2021 - 2024 ドラッグリポジショニングによる腫瘍微小環境を標的とした革新的治療法の開発
- 2021 - 2024 FusobacteriumによるNOD/NF-κBを介した食道癌進展機序の解明
- 2020 - 2023 革新的治療開発を目指した腸内細菌Fusobacteriumと腫瘍免疫の網羅的解析
- 2019 - 2022 Comprehensive analyses of the importance of mean corpuscular volume to estimate short-term and long-term outcomes in patients with esophageal squamous cell carcinoma who undergo esophagectomy
- 2018 - 2021 Fusobacterium nucleatum Confers Chemoresistance by Modulating Autophagy in Esophageal Squamous Cell Carcinoma
- 2018 - 2020 Comprehensive analysis of gut microbiome and sarcopenia in gastrointestinal cancers
- 2017 - 2020 Comprehensive analysis of gut microbiome and epigenetic changes in esophageal cancer.
- 2017 - 2020 Investigation of CCN family for development and drug resistance of gastrointestinal cancers
- 2017 - 2020 Comprehensive analysis of cancer cachexia signaling pathway for identifying a new therapeutic strategy in colorectal cancer.
- 2018 - 2020 Analysis of microbiome and epigenetics for the development of novel biomarker in Gastrointestinal cancers
- 2017 - 2019 Comprehensive analysis of gut microbiome before and after gastroenterological surgery.
- 2016 - 2019 The identification of molecular markers associated with resistance for molecular targeted agents in GIST
- 2016 - 2018 Functional analyses and developments of new therapies targeting LSD1 in gastrointestinal cancers
- 2015 - 2018 Global genomic analysis of the stromal compartments of the esophagus toward the establishment of novel treatment for esophageal cancer.
- 2015 - 2018 Comprehensive analysis to elucidate the mechanism of cancer metabolism in esophageal squamous cell carcinoma
- 2015 - 2018 Development of the new treatment strategy targeting microRNA which controls histone de-methylase
- 2014 - 2017 The identification of novel microRNAs regulating cancer stem cell properties and the clinical application to therapeutic strategy in gastrointestinal cancer
- 2014 - 2017 TET family proteins and 5-hydroxymethylcytosine in gastrointestinal carcinoma.
- 2014 - 2017 Clarification of the microRNA pathway regulating resistance to Trastuzumab in gastric cancer
- 2014 - 2017 Comprehensive analysis of mutation in PI3K/AKT pathway genes in esophageal cancer.
- 2014 - 2017 Epigenome analysis of cancer metabolism for the development of new biomarkers in esophageal cancer.
- 2015 - 2016 消化管癌の新規バイオマーカー開発をめざしたDNA脱メチル化関連酵素の網羅的解析
- 2013 - 2016 Tumor-suppressive effects and mechanism of a novel PPAR gamma agonist in esophageal caner
- 2012 - 2016 Individualized treatment strategy for esophageal cancer based on the expression of microRNAs in preoperative biopsy specimens.
- 2013 - 2015 Changes in expression levels of ERCC1, DPD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer
- 2012 - 2015 Comprehensive analysis of LINE-1 methylation level in gastric cancer.
- 2012 - 2015 The novel markers to predict the sensitivity to chemotherapy in ESCC and GC
- 2012 - 2014 Comprehensive analysis of IGF2 DMR0 methylation level in esophageal cancer
- 2011 - 2014 Comprehensive analysis of LINE-1 hypomethylation level aimed at the development of new treatments for esophageal cancer
- 2011 - 2013 Pseudogene affected gene expression via regulating microRNA in esopheal squamous cancer
- 2011 - 2013 Global analysis of genomic alterations associated with AKT and ERK pathway in esophageal squamous cell carcinoma
- 2011 - 2013 The significance of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer and for anticancer drug sensitivity marker.
- 2011 - 2013 p53 and autophagy in colorectal cancer : function mechanism and Therapeutic applications
- 2011 - 2012 Can mTOR become target of the molecular target therapy in esophagus squamous cell carcinoma?
Show all